75
Participants
Start Date
March 10, 2020
Primary Completion Date
December 10, 2020
Study Completion Date
December 10, 2020
Lamotrigine
Orally; 300 mg
Ketamine
Intravenously; 0.12 mg/kg during the first minute followed by a continuous infusion of approximately 0.31 mg/kg/h over approx. 40 min
Placebo Pretreatment
Lamotrigine Placebo
Placebo Infusion
Ketamine Placebo
Medical School Berlin, Berlin
Collaborators (1)
Boehringer Ingelheim
INDUSTRY
Charite University, Berlin, Germany
OTHER